INO
Inovio Pharmaceuticals Inc
1.30$
-3.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +288.0% | -12.8% | +19.4% | -27.8% | -86.5% | +80.2% | -76.1% | +478.2% | -91.9% | -73.8% | -70.0% | |
| – | +19.5% | +53.5% | +11.1% | -3.4% | -7.6% | +7.1% | -95.0% | +16.2% | -36.3% | -10.7% | -4.5% | |
| – | +288.0% | -12.8% | +19.4% | -27.8% | -86.5% | +80.2% | -76.1% | +478.2% | -91.9% | -450.0% | – | |
| – | +69.5% | +53.5% | +11.1% | -3.4% | -7.6% | +7.1% | +164.5% | -24.7% | -53.8% | -12.8% | -28.3% | |
| – | +13.9% | +32.3% | +18.4% | +3.6% | -7.2% | +36.9% | +44.3% | +67.8% | -47.2% | +77,652.6% | -99.9% | |
| – | +51.9% | +48.4% | +12.7% | -1.8% | -7.5% | +14.1% | +130.4% | -8.3% | -47.9% | -23.3% | -21.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +54.2% | -97.3% | -81.4% | +1,234.5% | +2,196.7% | +9.5% | -77.7% | -35.2% | -2.5% | -85.5% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +23.6% | -111.9% | – | -99.2% | +398.5% | -100.0% | -5,357,343,593,800.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.